Notice of Renewal / Resubmission / Revision Application Due Date Correction to PAR-24-172 "NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)"
Notice Number:
NOT-HL-24-011

Key Dates

Release Date:

April 15, 2024

Related Announcements

  • April 1, 2024 - NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required). See NOFO PAR-24-172. 

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice of Correction is to inform potential applicants that effective immediately, the first 2026 Renewal / Resubmission / Revision Application Due Date to PAR-24-172 "NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)" has been revised to February 03, 2026. 

The following text has been updated in bold and italics to reflect the correction::

Part 1. Overview Information

Key Dates

Application Due DatesReview and Award Cycles
NewRenewal / Resubmission / Revision (as allowed)AIDS - New/Renewal/Resubmission/Revision, as allowedScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
June 04, 2024June 04, 2024September 07, 2024 *November 2024January 2025April 2025
October 02, 2024October 02, 2024January 07, 2025 *March 2025May 2025July 2025
February 03, 2025February 03, 2025May 07, 2025 *July 2025October 2025December 2025
June 04, 2025June 04, 2025September 07, 2025 *November 2025January 2026April 2026
October 02, 2025October 02, 2025January 07, 2026 *March 2026May 2026July 2026
February 03, 2026February 03, 2026May 07, 2026 *July 2026October 2026December 2026
June 04, 2026June 04, 2026September 07, 2026 *November 2026January 2027April 2027
October 02, 2026October 02, 2026January 07, 2027 *March 2027May 2027July 2027

 All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Sumita Khatri, MD
Division of Lung Diseases 
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-402-9673 
Email: [email protected]

Daniel Frank, PhD
Division of Blood Diseases and Disorders
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-594-9405
Email: [email protected]   

Emily Tinsley, PhD
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0519
Email: [email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
NIH Office of Extramural Research Logo
Department of Health and Human Services (HHS) - Home Page
Department of Health
and Human Services (HHS)
USA.gov - Government Made Easy
NIH... Turning Discovery Into Health®